Yüklüyor......
Sorafenib/Regorafenib and Lapatinib interact to kill CNS tumor cells
The present studies were to determine whether the multi-kinase inhibitor sorafenib or its derivative regorafenib interacted with the ERBB1/ERBB2 inhibitor lapatinib to kill CNS tumor cells. In multiple CNS tumor cell types sorafenib and lapatinib interacted in a greater than additive fashion to caus...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4182138/ https://ncbi.nlm.nih.gov/pubmed/24911215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.24689 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|